Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 8,280.00
+280.00 (3.50%)
Apr 8, 2026, 3:30 PM KST
Tdspharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4,275 | 3,718 | 4,688 | 3,456 | 2,063 |
Depreciation & Amortization | 699.57 | 668.59 | 1,022 | 1,266 | 1,230 |
Loss (Gain) From Sale of Assets | -517.52 | 88.76 | -0.2 | -6.24 | -11.14 |
Asset Writedown & Restructuring Costs | - | - | - | 52.24 | - |
Provision & Write-off of Bad Debts | 41.05 | 67.36 | -3.05 | 8.06 | - |
Other Operating Activities | -632.63 | -187.02 | 363.21 | -24.36 | 361.45 |
Change in Accounts Receivable | -1,303 | 1,329 | -975.88 | -2,596 | 220.31 |
Change in Inventory | 526.73 | -658.37 | -330.23 | -268.36 | -199.46 |
Change in Accounts Payable | 722.39 | -727.35 | 46.36 | 971.97 | -53.58 |
Change in Other Net Operating Assets | -31.27 | -369.83 | -1,516 | 82.57 | 68.92 |
Operating Cash Flow | 3,780 | 3,929 | 3,294 | 2,942 | 3,680 |
Operating Cash Flow Growth | -3.79% | 19.29% | 11.94% | -20.04% | 66.36% |
Capital Expenditures | -12,884 | -715.7 | -213.82 | -625.42 | -200.89 |
Sale of Property, Plant & Equipment | 424.83 | 1.11 | 0.2 | 22.73 | 23.64 |
Sale (Purchase) of Intangibles | - | -1.74 | -57.55 | -5.5 | - |
Sale (Purchase) of Real Estate | 564 | - | - | - | - |
Investment in Securities | 6,946 | -12,500 | -4,527 | -515.58 | -1,478 |
Other Investing Activities | -2,988 | -14.57 | 28.39 | -93.91 | 15.55 |
Investing Cash Flow | -8,003 | -13,311 | -4,770 | -1,218 | -1,640 |
Short-Term Debt Issued | 1,594 | - | - | - | - |
Long-Term Debt Issued | - | - | 300 | 675 | - |
Total Debt Issued | 1,594 | - | 300 | 675 | - |
Short-Term Debt Repaid | - | - | - | -1,000 | - |
Long-Term Debt Repaid | -863.17 | -320.63 | -124.81 | -85.06 | -51.2 |
Total Debt Repaid | -863.17 | -320.63 | -124.81 | -1,085 | -51.2 |
Net Debt Issued (Repaid) | 730.82 | -320.63 | 175.19 | -410.06 | -51.2 |
Issuance of Common Stock | - | 13,390 | - | - | - |
Repurchase of Common Stock | - | - | - | - | -2,706 |
Other Financing Activities | - | -619.33 | -0 | - | - |
Financing Cash Flow | 730.82 | 12,450 | 175.19 | -410.06 | -2,757 |
Foreign Exchange Rate Adjustments | 0.02 | 0.02 | -0.21 | -0.04 | - |
Net Cash Flow | -3,492 | 3,068 | -1,301 | 1,315 | -717.28 |
Free Cash Flow | -9,104 | 3,213 | 3,080 | 2,317 | 3,479 |
Free Cash Flow Growth | - | 4.34% | 32.92% | -33.40% | 75.45% |
Free Cash Flow Margin | -32.96% | 11.68% | 10.25% | 9.05% | 17.55% |
Free Cash Flow Per Share | -1720.89 | 694.06 | 723.32 | 543.79 | 37650.19 |
Cash Interest Paid | 223.46 | 262.18 | 280.43 | 195.09 | 84.97 |
Cash Income Tax Paid | 1,419 | 572.49 | 679.93 | 561.14 | 150.9 |
Levered Free Cash Flow | -10,743 | 2,396 | 2,428 | 1,052 | 2,720 |
Unlevered Free Cash Flow | -10,604 | 2,563 | 2,617 | 1,190 | 2,801 |
Change in Working Capital | -84.98 | -426.39 | -2,776 | -1,809 | 36.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.